Since the reform and opening up 40 years ago，China’s pharmaceutical industry was one of the first industries to introduce international capital，technology and management experience. With the launching and deepening of the national reform and opening up policy，the timing for multinational pharmaceutical companies to enter the Chinese market could be basically divided into three phases. The first phase was the early 1980s，the second was after 1992，and the third was after 2000. With the development of social economy，the demand for health-care and medical products by Chinese residents was becoming stronger and stronger. It was believed that the depth and breadth of investment by multinational pharmaceutical companies in China would continue to increase. The relationship between Chinese domestic pharmaceutical companies and foreign-funded enterprises could be called a “competitive-cooperative relationship” rather than a competitive relationship. Domestic enterprises and foreign-funded enterprises had their own strengths，competing with each other and cooperating with each other.